Tenet Healthcare (NYSE:THC) Price Target Raised to $280.00

Tenet Healthcare (NYSE:THC) had its price target hoisted by Robert W. Baird from $210.00 to $280.00 in a report released on Tuesday, MarketBeat Ratings reports. The firm currently has a neutral rating on the stock.

THC has been the topic of several other research reports. TD Cowen lifted their price target on Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a report on Monday. Royal Bank Of Canada raised their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday. Morgan Stanley lifted their target price on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday. Piper Sandler set a $308.00 price target on shares of Tenet Healthcare in a research note on Monday. Finally, Wall Street Zen raised shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a research report on Sunday, July 26th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $268.50.

Tenet Healthcare Trading Down 1.9%

Shares of Tenet Healthcare stock opened at $252.80 on Tuesday. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The stock’s 50 day simple moving average is $190.49 and its 200-day simple moving average is $198.96. The stock has a market cap of $21.78 billion, a P/E ratio of 9.75, a P/E/G ratio of 0.98 and a beta of 1.27. Tenet Healthcare has a 1-year low of $156.71 and a 1-year high of $262.68.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare will post 21.09 EPS for the current fiscal year.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Christopher S. Lynch sold 3,837 shares of Tenet Healthcare stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $243.44, for a total transaction of $934,079.28. Following the sale, the director owned 9,568 shares of the company’s stock, valued at approximately $2,329,233.92. This represents a 28.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 23,353 shares of company stock worth $5,103,217. 0.97% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare in the third quarter valued at $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare during the 4th quarter worth about $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare in the 4th quarter valued at about $29,000. Meeder Asset Management Inc. increased its stake in Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of Tenet Healthcare during the second quarter worth about $35,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Analysts raised their price targets: Truist lifted its target to $290, while Guggenheim increased its target to $283 and Robert W. Baird raised its target to $280. The revisions reflect growing confidence in Tenet’s earnings outlook and imply additional upside from recent trading levels. Truist raises Tenet Healthcare price target Baird analyst comments on Tenet Healthcare Guggenheim analyst comments on Tenet Healthcare
• Positive Sentiment: Growth and momentum remain key attractions: Zacks highlighted Tenet’s above-average financial growth, strong momentum characteristics and potential appeal to growth-focused investors. These reports may support continued retail and quantitative-investor interest in THC. Three reasons growth investors may like Tenet Healthcare Tenet Healthcare momentum analysis
• Positive Sentiment: Fundamental performance supports the bullish case: Tenet’s latest quarterly results exceeded estimates, with EPS of $6.12 versus a $4.26 consensus and revenue of $6.04 billion versus $5.43 billion expected. The company also raised its 2026 outlook, strengthening the investment case behind the recent rally.
• Neutral Sentiment: Investor attention is elevated: Zacks reported increased user interest in Tenet and noted that the stock recently reached a 52-week high. However, the coverage is largely informational and does not represent a new company announcement or change in fundamentals. Zacks analysis of investor attention on Tenet Healthcare
• Negative Sentiment: Insider selling creates a modest overhang: EVP Paola Arbour sold 10,878 shares for approximately $2.65 million, while Director Christopher Lynch sold 3,837 shares worth about $934,000. Both transactions significantly reduced their holdings, although the sales may reflect personal financial planning rather than a negative view of Tenet’s prospects.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.